These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8372058)

  • 1. Effects of caffeine in diazepam withdrawal syndrome in mice.
    Pesce ME; Acevedo X; Miranda HF
    Pharmacol Toxicol; 1993; 72(4-5):341-2. PubMed ID: 8372058
    [No Abstract]   [Full Text] [Related]  

  • 2. Gender differences in diazepam withdrawal syndrome in mice.
    Pesce ME; Acevedo X; Pinardi G; Miranda HF
    Pharmacol Toxicol; 1994 Dec; 75(6):353-5. PubMed ID: 7899256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precipitation of abstinence in nordiazepam- and diazepam-dependent dogs.
    McNicholas LF; Martin WR; Sloan JW; Wala E
    J Pharmacol Exp Ther; 1988 Apr; 245(1):221-4. PubMed ID: 3129550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice.
    Kuribara H; Stavinoha WB; Maruyama Y
    J Pharm Pharmacol; 1998 Jul; 50(7):819-26. PubMed ID: 9720634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.
    Bilbao A; Cippitelli A; Martín AB; Granado N; Ortiz O; Bezard E; Chen JF; Navarro M; Rodríguez de Fonseca F; Moratalla R
    Psychopharmacology (Berl); 2006 Apr; 185(2):160-8. PubMed ID: 16470403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locomotor activity in mice during chronic treatment with caffeine and withdrawal.
    Nikodijević O; Jacobson KA; Daly JW
    Pharmacol Biochem Behav; 1993 Jan; 44(1):199-216. PubMed ID: 7679219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of tolerance or withdrawal effects in mice after chronic administration of the non-sedating anxiolytic, CGS 9896.
    Boast CA; Gerhardt SC
    Pharmacol Biochem Behav; 1987 Mar; 26(3):601-6. PubMed ID: 3575376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users.
    Mintzer MZ; Stoller KB; Griffiths RR
    Psychopharmacology (Berl); 1999 Nov; 147(2):200-9. PubMed ID: 10591888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locomotor activity pattern induced by diazepam in control and caffeine-treated mice.
    Sansone M; Pavone F; Battaglia M; Vetulani J
    Pol J Pharmacol; 1995; 47(5):387-92. PubMed ID: 8868129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of prolonged caffeine administration and its withdrawal on pilocarpine- and kainate-induced seizures in rats.
    Hoexter MQ; Rosa PS; Tufik S; Mello LE
    Epilepsia; 2005 Sep; 46(9):1401-6. PubMed ID: 16146434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of caffeine-induced seizures in mice by Ro15-1788.
    Vellucci SV; Webster RA
    Eur J Pharmacol; 1984 Jan; 97(3-4):289-93. PubMed ID: 6423394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine inhibition of [3H]flunitrazepam binding and caffeine-induced seizures in mice.
    Chweh AY; Ulloque RA; Swinyard EA
    Eur J Pharmacol; 1986 Mar; 122(2):161-5. PubMed ID: 2872063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of barbital or diazepam withdrawal on seizure thresholds to bicuculline, picrotoxin and flurazepam.
    Reigel CE; Bourn WM
    Proc West Pharmacol Soc; 1995; 38():45-7. PubMed ID: 7480017
    [No Abstract]   [Full Text] [Related]  

  • 14. Corticosterone increases severity of acute withdrawal from ethanol, pentobarbital, and diazepam in mice.
    Roberts AJ; Crabbe JC; Keith LD
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):278-84. PubMed ID: 7862907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA Receptors and NO:cGMP Signaling Pathway Mediate the Diazepam-Induced Sensitization to Withdrawal Signs in Mice.
    Talarek S; Listos J; Orzelska-Gorka J; Serefko A; Kotlińska J
    Neurotox Res; 2018 Feb; 33(2):422-432. PubMed ID: 28936791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol- and diazepam-withdrawal hyperlocomotion is not due to 5-HT3 receptor stimulation.
    Mehta AK; Ticku MK
    Pharmacol Biochem Behav; 1993 Jul; 45(3):755-7. PubMed ID: 8332636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol and diazepam withdrawal convulsions are extensively codetermined in WSP and WSR mice.
    Belknap JK; Crabbe JC; Laursen SE
    Life Sci; 1989; 44(26):2075-80. PubMed ID: 2501607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal effects of diazepam-withdrawal are linked to activation of central cholecystokinin-ergic pathways in rats.
    Bonnafous C; Martinez J; Bueno L
    J Pharm Pharmacol; 1994 Oct; 46(10):784-8. PubMed ID: 7699563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitisation of withdrawal signs following repeated withdrawal from a benzodiazepine: differences between measures of anxiety and seizure sensitivity.
    Ward BO; Stephens DN
    Psychopharmacology (Berl); 1998 Feb; 135(4):342-52. PubMed ID: 9539258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodic benzodiazepine antagonist administration prevents benzodiazepine withdrawal symptoms in primates.
    Gallager DW; Heninger K; Heninger G
    Eur J Pharmacol; 1986 Dec; 132(1):31-8. PubMed ID: 3102259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.